Please ensure Javascript is enabled for purposes of website accessibility
Home / Products / Research Biosimilar

Research Grade Tebotelimab (DHD30407)

Host species:Humanized
Isotype:[V-kappa’-VH-h-CH2-CH3_V-kappa-VH’]2
Applications:Research Grade Biosimilar
Expression system:Mammalian Cells
Overview

Catalog No.

DHD30407

Expression system

Mammalian Cells

Species reactivity

Human

Host species

Humanized

Isotype

[V-kappa’-VH-h-CH2-CH3_V-kappa-VH’]2

Clonality

Monoclonal

Target

FDC, LAG3, Lymphocyte activation gene 3 protein, CD223, sLAG-3, LAG-3, Programmed cell death protein 1, Protein PD-1, hPD-1, PD1, PDCD1, CD279

Concentration

1 mg/ml

Endotoxin level

Please contact with the lab for this information.

Purity

>95% as determined by SDS-PAGE.

Purification

Protein A/G purified from cell culture supernatant.

Accession

P18627 & Q15116

Applications

Research Grade Biosimilar

Form

Liquid

Storage buffer

0.01M PBS, pH 7.4.

Stability and Storage

Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C short term (1-2 weeks). Store at -20°C 12 months. Store at -80°C long term.

Alternative Names

Bispecific, MGD-013, CAS: 2245725-04-4

Clone ID

Tebotelimab

Data Image
  • SDS-PAGE
    SDS PAGE for Tebotelimab
References
Datasheet

Document Download

Research Grade Tebotelimab.pdf

 

$ 484
Product specifications
100 μg 484 1 mg 1932

Contact Information

Order: order@antibodysystem.com

Mail: support@antibodysystem.com

Distributor list

For research use only. Not for human or drug use.

Need help with your order?

Find out more about placing an order here

Research Grade Tebotelimab [DHD30407]
Terms of sale Website terms of use Cookie policy Privacy
Copyright © 2024 AntibodySystem SAS. All Rights Reserved.            All Products are for Research Use Only